Daniela Weiskopf

Citado por

	Total	Desde 2020
Citas	34801	29747
Índice h	72	62
Índice i10	144	141

9000

4500

2250

6750

2010201120122013201420152016201720182019202020212022202320242025129 182 196 260 717 397 465 631 860 987 2706 6971 8718 6203 4447 496

Acceso público

Ver todo

194 artículos

3 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Alessandro SetteDirección de correo verificada de liai.org
Alba GrifoniResearch Assistant Professor, La Jolla Institute for immunologyDirección de correo verificada de lji.org
Bjoern PetersProfessor at La Jolla Institute for ImmunologyDirección de correo verificada de lji.org
Shane CrottyProfessor and CSO, La Jolla Institute for ImmunologyDirección de correo verificada de lji.org
John SidneyLa Jolla Institute for AllergyDirección de correo verificada de lji.org
Jennifer DanDirección de correo verificada de lji.org
Jose MateusScientist, Vividion TherapeuticsDirección de correo verificada de vividion.com
Aruna Dharshan De SilvaProfessor, Faculty of Medicine, General Sir John Kotelawala Defence University, Sri LankaDirección de correo verificada de kdu.ac.lk
Ricardo da Silva AntunesLa Jolla Institute for Allergy and ImmunologyDirección de correo verificada de lji.org
Sydney Ilima RamirezUC San Diego, La Jolla Institute for ImmunologyDirección de correo verificada de lji.org
Stephen Arthur RawlingsInfectious Diseases Physician, Maine Medical CenterDirección de correo verificada de mainehealth.org
Davey SmithProfessor of Medicine, University of California, San DiegoDirección de correo verificada de ucsd.edu
Esther Dawen YuLa Jolla Institute for ImmunologyDirección de correo verificada de lji.org
Simon MallalDirector, Institute for Immunology and Infectious Diseases, Murdoch University, Western AustraliaDirección de correo verificada de iiid.com.au
Cecilia Lindestam ArlehamnLa Jolla Institute for Allergy and ImmunologyDirección de correo verificada de liai.org
Florian KrammerIcahn School of Medicine at Mount SinaiDirección de correo verificada de mssm.edu
Michael A. AngeloBristol Myers SquibbDirección de correo verificada de bms.com
Gregory SeumoisResearch Assistant Professor, La Jolla Institute for ImmunologyDirección de correo verificada de lji.org
Sinu PaulBioinformatics Scientist, Rancho BiosciencesDirección de correo verificada de ranchobiosciences.com
Pandurangan VijayanandProfessor, La Jolla Institute for ImmunologyDirección de correo verificada de lji.org

Seguir

Daniela Weiskopf

La Jolla Institute for Immunology

Dirección de correo verificada de lji.org - Página principal

Immunology T cells MHC infectious diseases


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals A Grifoni, D Weiskopf, SI Ramirez, J Mateus, JM Dan, CR Moderbacher, ... Cell 181 (7), 1489-1501. e15, 2020	4242	2020
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection JM Dan, J Mateus, Y Kato, KM Hastie, ED Yu, CE Faliti, A Grifoni, ... Science 371 (6529), eabf4063, 2021	3099	2021
Induction of autophagy by spermidine promotes longevity T Eisenberg, H Knauer, A Schauer, S Büttner, C Ruckenstuhl, ... Nature cell biology 11 (11), 1305-1314, 2009	2146	2009
Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity CR Moderbacher, SI Ramirez, JM Dan, A Grifoni, KM Hastie, D Weiskopf, ... Cell 183 (4), 996-1012. e19, 2020	1948	2020
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans J Mateus, A Grifoni, A Tarke, J Sidney, SI Ramirez, JM Dan, ZC Burger, ... Science 370 (6512), 89-94, 2020	1250	2020
The aging of the immune system D Weiskopf, B Weinberger, B Grubeck‐Loebenstein Transplant international 22 (11), 1041-1050, 2009	1044	2009
Phenotype and kinetics of SARS-CoV-2–specific T cells in COVID-19 patients with acute respiratory distress syndrome D Weiskopf, KS Schmitz, MP Raadsen, A Grifoni, NMA Okba, H Endeman, ... Science immunology 5 (48), eabd2071, 2020	1018	2020
The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients L Premkumar, B Segovia-Chumbez, R Jadi, DR Martinez, R Raut, ... Science immunology 5 (48), eabc8413, 2020	952	2020
Properties of MHC class I presented peptides that enhance immunogenicity JJA Calis, M Maybeno, JA Greenbaum, D Weiskopf, AD De Silva, A Sette, ... PLoS computational biology 9 (10), e1003266, 2013	911	2013
mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern RR Goel, MM Painter, SA Apostolidis, D Mathew, W Meng, AM Rosenfeld, ... Science 374 (6572), abm0829, 2021	844	2021
T cells from patients with Parkinson’s disease recognize α-synuclein peptides D Sulzer, RN Alcalay, F Garretti, L Cote, E Kanter, J Agin-Liebes, C Liong, ... Nature 546 (7660), 656-661, 2017	824	2017
SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron A Tarke, CH Coelho, Z Zhang, JM Dan, ED Yu, N Methot, NI Bloom, ... Cell 185 (5), 847-859. e11, 2022	791	2022
Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells D Weiskopf, MA Angelo, EL de Azeredo, J Sidney, JA Greenbaum, ... Proceedings of the National Academy of Sciences 110 (22), E2046-E2053, 2013	659	2013
Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals A Tarke, J Sidney, N Methot, ED Yu, Y Zhang, JM Dan, B Goodwin, ... Cell Reports Medicine 2 (7), 2021	585	2021
T cell responses to SARS-CoV-2 spike cross-recognize Omicron R Keeton, MB Tincho, A Ngomti, R Baguma, N Benede, A Suzuki, K Khan, ... Nature 603 (7901), 488-492, 2022	577	2022
A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2 AO Hassan, NM Kafai, IP Dmitriev, JM Fox, BK Smith, IB Harvey, RE Chen, ... Cell 183 (1), 169-184. e13, 2020	565	2020
Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases A Tarke, J Sidney, CK Kidd, JM Dan, SI Ramirez, ED Yu, J Mateus, ... Cell Reports Medicine 2 (2), 2021	557	2021
Imbalance of regulatory and cytotoxic SARS-CoV-2-reactive CD4+ T cells in COVID-19 BJ Meckiff, C Ramírez-Suástegui, V Fajardo, SJ Chee, A Kusnadi, ... Cell 183 (5), 1340-1353. e16, 2020	542	2020
Biology of immune responses to vaccines in elderly persons B Weinberger, D Herndler-Brandstetter, A Schwanninger, D Weiskopf, ... Clinical Infectious Diseases 46 (7), 1078-1084, 2008	525	2008
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy SA Apostolidis, M Kakara, MM Painter, RR Goel, D Mathew, K Lenzi, ... Nature medicine 27 (11), 1990-2001, 2021	487	2021

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores